Histogen Inc Sustainability Reports
Histogen Inc. operates as a clinical-stage therapeutics company. It focuses on developing targeted solutions across broad therapeutic indications, including joint cartilage regeneration, spinal disk repair, and other soft tissue applications.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300XHWPP338YQ8O67
FIGI: BBG001T99KX6
2 reports from 2020 to 2022
